Catalyst Pharmaceuticals, Inc.

NasdaqCM:CPRX Stock Report

Market Cap: US$2.4b

Catalyst Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:CPRX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
20 Aug 24SellUS$3,052,900Steven MillerIndividual150,000US$20.59
09 Aug 24SellUS$111,710Jeffrey Del CarmenIndividual6,058US$18.44
07 Jun 24SellUS$121,184Jeffrey Del CarmenIndividual7,541US$16.07
03 Jun 24SellUS$86,949Molly HarperIndividual5,333US$16.30
27 Mar 24SellUS$411,000Brian ElsberndIndividual25,000US$16.44
15 Dec 23SellUS$57,720Molly HarperIndividual4,000US$14.43
05 Dec 23SellUS$569,600Steven MillerIndividual40,000US$14.24

Insider Trading Volume

Insider Buying: CPRX insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of CPRX?
Owner TypeNumber of SharesOwnership Percentage
State or Government50,5900.0426%
Individual Insiders7,074,7825.96%
Hedge Funds9,127,3057.69%
General Public13,616,38211.5%
Institutions88,818,83874.8%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 11.3%.

Top Shareholders

Top 25 shareholders own 65.75% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
15.8%
BlackRock, Inc.
18,694,918US$378.0m5.43%0.01%
7.69%
Deerfield Management Company, L.P. Series C
9,127,305US$184.6m-0.04%2.92%
6.82%
The Vanguard Group, Inc.
8,100,355US$163.8m1.5%no data
5.08%
State Street Global Advisors, Inc.
6,033,298US$122.0m-26%no data
3.77%
Patrick McEnany
4,478,169US$90.5m-1.11%no data
2.53%
Dimensional Fund Advisors LP
3,000,756US$60.7m9.61%0.01%
2.5%
Pacer Advisors, Inc.
2,967,575US$60.0m131,000%0.14%
2.27%
Geode Capital Management, LLC
2,698,613US$54.6m7.59%no data
2.08%
First Trust Advisors LP
2,472,933US$50.0m1,000%0.04%
1.83%
Renaissance Technologies LLC
2,175,727US$44.0m15.2%0.07%
1.83%
Janus Henderson Group plc
2,175,641US$44.0m-20.2%0.02%
1.82%
Royce & Associates, LP
2,162,022US$43.7m3.74%0.37%
1.18%
Boston Partners Global Investors, Inc.
1,406,380US$28.4m-6.67%0.02%
1.17%
Northern Trust Global Investments
1,386,707US$28.0m-3.01%no data
1.13%
Jacobs Levy Equity Management Inc
1,341,564US$27.1m6.82%0.11%
1.08%
Kennedy Capital Management LLC
1,276,304US$25.8m20.2%0.52%
1.04%
T. Rowe Price Group, Inc.
1,232,852US$24.9m1.1%no data
1.03%
Marshall Wace LLP
1,219,537US$24.7m-27.6%0.04%
0.94%
Charles Schwab Investment Management, Inc.
1,116,939US$22.6m3.85%no data
0.79%
Mesirow Financial Investment Management, Inc.
934,234US$18.9m29.9%0.31%
0.74%
LSV Asset Management
873,900US$17.7m-2.47%0.03%
0.7%
BNY Asset Management
834,415US$16.9m2.07%no data
0.69%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
824,731US$16.7m45.6%no data
0.64%
Voloridge Investment Management, LLC
754,725US$15.3m-30.3%0.05%
0.63%
Morgan Stanley, Investment Banking and Brokerage Investments
746,941US$15.1m-52%no data